Recent Quotes (30 days)

You have no recent quotes
chg | %

LivaNova PLC  

(Public, LON:LIVN)   Watch this stock  
Find more results forLIVN
LON real-time data - Disclaimer
Currency in
Range     -
52 week 41.21 - 63.00
Open     -
Vol / Avg. 0.00/1,913.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.29
Shares 48.18M
Beta     -
Inst. own 92%

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 19.57% -3.31%
Operating margin 21.94% -2.28%
EBITD margin - 12.55%
Return on average assets 10.29% -1.64%
Return on average equity 10.65% -3.57%
Employees 4,500 -
CDP Score - -


20 Eastbourne Terrace
United Kingdom - Map
+44-20-37865275 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.

Officers and directors

Daniel Jeffrey Moore Chairman of the Board
Age: 56
Damien McDonald Chief Executive Officer, Director
Age: 52
Thad Allen Huston Chief Financial Officer
Douglas J. Manko Chief Accounting Officer
Age: 43
David S. Wise Chief Administrative Officer
Age: 62
Francesco Bianchi Independent Director
Age: 60
Stefano Gianotti Independent Director
Age: 54
Hugh M. Morrison Independent Director
Age: 70
Alfred J. Novak Independent Director
Age: 69
Sharon O'Kane Ph.D. Independent Director
Age: 49